SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Full list of Israeli startup M&As in 2025

Zencity acquires UK’s Commonplace to expand global community engagement

Gong signs $8.45 million lease as it expands its R&D center in Ramat Gan

Adam Neumann-backed Canada Global buys 74 dunams in Miami for $70.5M

Buzz

Most popular

Daily

Weekly

1

Sam Altman-backed Apex Security in advanced talks to be acquired by Varonis for up to $40M

2

"Everyone will be a manager" - what the world of work will look like with AI agents

3

Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M

4

What went wrong at AnyVision? Lessons from a $352M flameout

5

Mitiga raises $30M Series B to defend cloud services from cyberattacks

Richard Francis

2 stories about Richard Francis

ריצרד פרנסיס נשיא ו מנכל חברה חברת טב

Teva soars with double-digit growth in Q3, raises annual forecast

06.11.24|Sophie Shulman

Strong sales of Austedo and Ajovy push Teva’s revenues above expectations, with the company forecasting up to $16.5 billion in 2024.

מפגש עיתונאים ראשון עם נשיא ומנכל חברת טבע ריצ'רד פרנסיס

Teva CEO: "The company played not to lose, now we’ll play to win"

21.02.24|Sophie Shulman

Richard Francis' decision to focus on innovative drugs has boosted the stock by 40% since he took office. However, the high debt is still burdensome and the realization of the potential depends on the success of developments that are still in the laboratory